Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

Press releases published on October 5, 2026

Oct. 5, 2026

Curia ลงทุน 28 ล้านดอลลาร์สหรัฐฯ ในการผลิตสารออกฤทธิ์ทางเภสัชกรรม (Active Pharmaceutical Ingredient: API) ปลอดเชื้อ

Indeterminate GlobeNewswire

Oct. 5, 2026

Curia 投资 2,800 万美元扩大无菌原料药产能

Indeterminate GlobeNewswire

Oct. 5, 2026

Curia 投資 2,800 萬美元於無菌有效藥劑成分製造

Indeterminate GlobeNewswire

Oct. 5, 2026

AnorTech Secures Strategic Cornerstone as Greenland Mines Doubles Stake to 19.9%

Indeterminate GlobeNewswire

Oct. 5, 2026

Foresight to Present at the LD Micro 20th Annual Main Event Conference

Indeterminate GlobeNewswire

Oct. 5, 2026

Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Greenland Mines Doubles AnorTech Stake to 19.9%; Extends Critical-Minerals Platform to Smelter-Grade Alumina, Lunar Construction Materials

Indeterminate GlobeNewswire

Oct. 5, 2026

Cyabra Awarded Positions on FBI Multi-Award IDIQ Contract for Specialized Open-Source Intelligence (OSINT) Tools

Indeterminate GlobeNewswire

Oct. 5, 2026

Aprea Therapeutics to Present at October Conferences

Indeterminate GlobeNewswire

Oct. 5, 2026

PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Northern Discovery Metals Completes Fieldwork at the Vent Copper Project

Indeterminate GlobeNewswire

Oct. 5, 2026

Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project

Indeterminate GlobeNewswire

Oct. 5, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer

Indeterminate GlobeNewswire

Oct. 5, 2026

Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer

Indeterminate GlobeNewswire

Oct. 5, 2026

OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the IGCS 2026 Annual Global Meeting

Indeterminate GlobeNewswire

Oct. 5, 2026

Sofwave to Participate in the Jefferies Private MedTech Virtual Summit

Indeterminate GlobeNewswire

Oct. 5, 2026

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

Indeterminate GlobeNewswire

Oct. 5, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Indeterminate GlobeNewswire

Oct. 5, 2026

Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study

Indeterminate GlobeNewswire

Oct. 5, 2026

MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network

Indeterminate GlobeNewswire